Why do hospitals keep running out of generic drugs?

Key takeaways

Drug shortages in hospitals are an ongoing crisis, particularly affecting essential generic medications.
Economic principles of supply and demand do not effectively address the complexities of drug shortages in the healthcare system.
Manufacturing challenges, including regulatory compliance and limited suppliers, significantly contribute to the crisis of drug availability.
Hospitals’ purchasing strategies focusing on cost reduction lead to increased vulnerabilities in the supply chain.
Addressing drug shortages requires systemic change, including adjustments to pricing structures, government policies, and hospital practices.

Summary

The Ongoing Drug Shortage Crisis

This episode delves into the perplexing issue of drug shortages in hospitals, particularly focusing on generic sterile injectables like dextrose and saline. Jared, a nurse in the Mountain West, highlights that these shortages have been a constant aspect of his career, impacting routine treatments and causing significant concern among healthcare professionals.

Understanding the Economics Behind Shortages

Hosted by Sally Helm and Alexi Horowitz-Ghazi, the conversation shifts to the economic principles underlying these drug shortages. Despite the market's reliance on supply and demand, the healthcare system reveals complexities. The discussion explores how persistent shortages challenge basic economic assumptions and the paradox of prices that remain low despite high demand.

Challenges in Drug Manufacturing

Experts, including Marta Voshinska, a healthcare economist, provide insight into the manufacturing issues that contribute to shortages. The episode explains that generic sterile injectables are prone to shortages due to manufacturing problems, regulatory challenges, and the fact that many critical drugs are produced by only a few suppliers, making the supply chain vulnerable.

The Role of Pricing and Hospital Practices

The episode further investigates the role of pricing in drug shortages, discussing how low prices dissuade manufacturers from investing in production. Hospitals' purchasing practices are also examined—through group purchasing organizations that drive down costs, the focus on price leads to greater vulnerability in the supply chain, risking availability during critical times.

Proposed Solutions and Systemic Changes

As the discussion unfolds, potential solutions to the shortage problem are proposed. Suggestions include reforming government policies, creating incentives for hospitals to prioritize reliability in drug suppliers, and increasing financial support for manufacturers to bolster their production capabilities. Highlighted is the need for a systemic change in the healthcare supply chain to ensure patient care isn’t compromised.

Show notes

There's something strange going on in hospitals. Cheap, common drugs that nurses use every day seem to be constantly hit by shortages. These are often generic drugs that don't seem super complicated to make, things like dextrose and saline (aka sugar water and salt water).

So what's going on? The answer, as with anything in healthcare, is complicated.

On today's show: why hospitals keep running out of generic drugs. The story behind these shortages tells us a lot about how these drugs are made, bought and sold–and, it shows us how these markets can falter without the proper care.

This episode was hosted by Sally Helm and Alexi Horowitz-Ghazi. It was produced by Willa Rubin, with help from James Sneed and Sam Yellowhorse Kesler. It was edited by Martina Castro. Fact-checking by Dania Suleman. Planet Money's executive producer is Alex Goldmark.

Help support Planet Money and hear our bonus episodes by subscribing to Planet Money+ in Apple Podcasts or at plus.npr.org/planetmoney.

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy